Variant report

Variant	esv3358306
Chromosome Location	chr6:44236999-44239947
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr6:44237921-44238001	H1-hESC	embryonic stem cell:	n/a	n/a
2	CCNT2	chr6:44238420-44238817	K562	blood:	n/a	chr6:44238423-44238432
3	CTCF	chr6:44238520-44238670	SK-N-SH_RA	brain:	n/a	n/a
4	CTCF	chr6:44238400-44238550	GM12874	blood:	n/a	n/a
5	CTCF	chr6:44237380-44237530	K562	blood:	n/a	n/a
6	CTCF	chr6:44237780-44237930	AG09319	gingival:	n/a	n/a
7	EBF1	chr6:44237079-44237130	GM12878	blood:	n/a	n/a
8	EGR1	chr6:44238652-44238863	K562	blood:	n/a	n/a
9	ELF1	chr6:44238630-44238866	K562	blood:	n/a	chr6:44238637-44238649
10	EP300	chr6:44238361-44238818	H1-hESC	embryonic stem cell:	n/a	chr6:44238639-44238655
11	EP300	chr6:44237095-44237274	GM12878	blood:	n/a	chr6:44237126-44237133
12	FOS	chr6:44237500-44237560	MCF10A-Er-Src	breast:	n/a	n/a
13	FOS	chr6:44237111-44237165	MCF10A-Er-Src	breast:	n/a	n/a
14	FOXA1	chr6:44239688-44239984	A549	lung:	n/a	n/a
15	FOXA1	chr6:44239635-44239943	A549	lung:	n/a	n/a
16	HMGN3	chr6:44238427-44238486	K562	blood:	n/a	n/a
17	JUND	chr6:44238630-44238812	H1-hESC	embryonic stem cell:	n/a	n/a
18	MAX	chr6:44238488-44238976	H1-hESC	embryonic stem cell:	n/a	n/a
19	MAZ	chr6:44238298-44239163	IMR90	lung:	n/a	chr6:44238381-44238391 chr6:44239104-44239114
20	MAZ	chr6:44238602-44238945	K562	blood:	n/a	n/a
21	MAZ	chr6:44238730-44238919	GM12878	blood:	n/a	n/a
22	MYC	chr6:44238616-44238727	MCF-7	breast:	n/a	n/a
23	NR3C1	chr6:44239612-44240144	A549	lung:	n/a	chr6:44239860-44239876 chr6:44239861-44239875 chr6:44239860-44239876 chr6:44239861-44239875 chr6:44239860-44239876 chr6:44239985-44239994
24	NR3C1	chr6:44239615-44240080	A549	lung:	n/a	chr6:44239860-44239876 chr6:44239861-44239875 chr6:44239860-44239876 chr6:44239861-44239875 chr6:44239860-44239876 chr6:44239985-44239994
25	NR3C1	chr6:44239645-44239958	A549	lung:	n/a	chr6:44239860-44239876 chr6:44239861-44239875 chr6:44239860-44239876 chr6:44239861-44239875 chr6:44239860-44239876
26	POLR2A	chr6:44237840-44239211	H1-neurons	neurons:	n/a	n/a
27	POLR2A	chr6:44238649-44238965	H1-hESC	embryonic stem cell:	n/a	n/a
28	POLR2A	chr6:44237786-44239191	H1-neurons	neurons:	n/a	n/a
29	REST	chr6:44238680-44239041	PANC-1	pancreas:	n/a	chr6:44238836-44238849
30	REST	chr6:44238306-44239041	ECC-1	luminal epithelium:	n/a	chr6:44238836-44238849 chr6:44238436-44238446
31	REST	chr6:44238647-44239071	A549	lung:	n/a	chr6:44238836-44238849
32	REST	chr6:44238656-44239039	MCF-7	breast:	n/a	chr6:44238836-44238849
33	REST	chr6:44238549-44239073	PANC-1	pancreas:	n/a	chr6:44238836-44238849
34	REST	chr6:44238651-44238901	SK-N-SH	brain:	n/a	chr6:44238836-44238849
35	REST	chr6:44238671-44238906	U87	brain:	n/a	chr6:44238836-44238849
36	REST	chr6:44238614-44238964	SK-N-SH	brain:	n/a	chr6:44238836-44238849
37	REST	chr6:44238657-44238859	SK-N-SH	brain:	n/a	chr6:44238836-44238849
38	REST	chr6:44238588-44238922	HepG2	liver:	n/a	chr6:44238836-44238849
39	REST	chr6:44238725-44238820	PANC-1	pancreas:	n/a	n/a
40	REST	chr6:44238681-44238868	PFSK-1	brain:	n/a	chr6:44238836-44238849
41	REST	chr6:44238680-44238821	GM12878	blood:	n/a	n/a
42	REST	chr6:44238535-44239067	ECC-1	luminal epithelium:	n/a	chr6:44238836-44238849
43	REST	chr6:44238671-44238802	U87	brain:	n/a	n/a
44	REST	chr6:44238628-44238941	U87	brain:	n/a	chr6:44238836-44238849
45	REST	chr6:44238539-44238967	H1-hESC	embryonic stem cell:	n/a	chr6:44238836-44238849
46	REST	chr6:44238689-44238830	A549	lung:	n/a	n/a
47	REST	chr6:44238598-44239252	PFSK-1	brain:	n/a	chr6:44238836-44238849
48	REST	chr6:44238626-44238987	U87	brain:	n/a	chr6:44238836-44238849
49	REST	chr6:44238579-44239011	K562	blood:	n/a	chr6:44238836-44238849
50	REST	chr6:44238627-44238888	PANC-1	pancreas:	n/a	chr6:44238836-44238849

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:44239208-44239258	HPAEpiC	pulmonary alveolar:	n/a
2	chr6:44237813-44237863	HCM	heart:	n/a
3	chr6:44239208-44239258	HPAEpiC	pulmonary alveolar:	n/a
4	chr6:44237813-44237863	HCM	heart:	n/a
5	chr6:44239416-44239466	GM12878	blood:	n/a
6	chr6:44237813-44237863	SK-N-MC	brain:	n/a
7	chr6:44238228-44238278	ECC-1	luminal epithelium:	n/a
8	chr6:44238905-44238955	Jurkat	blood:	n/a
9	chr6:44238905-44238955	SK-N-SH	brain:	n/a
10	chr6:44237813-44237863	NHDF-neo	bronchial:	n/a
11	chr6:44238413-44238463	HEK293	kidney:	embryo
12	chr6:44238413-44238463	Hela-S3	cervix:	n/a
13	chr6:44239208-44239258	SK-N-MC	brain:	n/a
14	chr6:44238413-44238463	HCPEpiC	choroid plexus:	n/a
15	chr6:44238413-44238463	Caco-2	colon:	n/a
16	chr6:44238228-44238278	GM19239	blood:	n/a
17	chr6:44238413-44238463	AG04450	lung:	fetal
18	chr6:44238905-44238955	RPTEC	kidney:	n/a
19	chr6:44238228-44238278	LNCaP	prostate:	n/a
20	chr6:44238228-44238278	AG09319	gingival:	n/a
21	chr6:44239208-44239258	Hepatocyte	liver:	n/a
22	chr6:44238905-44238955	T-47D	breast:	n/a
23	chr6:44238228-44238278	HIPEpiC	eye:	n/a
24	chr6:44238228-44238278	PANC-1	pancreas:	n/a
25	chr6:44239416-44239466	ovcar-3	ovarian:	n/a
26	chr6:44238905-44238955	HAEpiC	amniotic membrane:	n/a
27	chr6:44238413-44238463	NB4	blood:	n/a
28	chr6:44237813-44237863	NB4	blood:	n/a
29	chr6:44238228-44238278	Hepatocyte	liver:	n/a
30	chr6:44238905-44238955	NHBE	bronchial:	n/a
31	chr6:44238905-44238955	BE2_C	brain:	n/a
32	chr6:44239208-44239258	SK-N-SH_RA	brain:	n/a
33	chr6:44237813-44237863	HEEpiC	esophagus:	n/a
34	chr6:44239416-44239466	A549	lung:	n/a
35	chr6:44238426-44238476	HRE	kidney:	n/a
36	chr6:44237813-44237863	AG09319	gingival:	n/a
37	chr6:44238413-44238463	ovcar-3	ovarian:	n/a
38	chr6:44237813-44237863	Hepatocyte	liver:	n/a
39	chr6:44237813-44237863	HRCEpiC	kidney:	n/a
40	chr6:44238228-44238278	ovcar-3	ovarian:	n/a
41	chr6:44238413-44238463	A549	lung:	n/a
42	chr6:44238413-44238463	HRE	kidney:	n/a
43	chr6:44237813-44237863	AoSMC	blood vessel:	n/a
44	chr6:44239208-44239258	ECC-1	luminal epithelium:	n/a
45	chr6:44238413-44238463	H1-hESC	embryonic stem cell:	embryo
46	chr6:44238426-44238476	SK-N-SH_RA	brain:	n/a
47	chr6:44238905-44238955	HL-60	blood:	n/a
48	chr6:44238413-44238463	AoSMC	blood vessel:	n/a
49	chr6:44238413-44238463	AG10803	skin:	n/a
50	chr6:44238426-44238476	U87	brain:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:44237771..44241790-chr6:44264717..44266725,3	MCF-7	breast:
2	chr6:44235214..44237013-chr6:44305028..44307078,2	MCF-7	breast:
3	chr6:44234643..44237474-chr6:44296098..44297940,2	MCF-7	breast:
4	chr6:44234588..44237594-chr6:44277478..44280850,3	MCF-7	breast:
5	chr6:44233082..44237547-chr6:44353791..44357282,5	MCF-7	breast:
6	chr6:44231911..44234847-chr6:44237510..44240187,2	MCF-7	breast:
7	chr6:43857455..43859614-chr6:44235657..44237353,2	K562	blood:

Variant related genes	Relation type
TMEM151B	TF binding region
ENSG00000272442	TF binding region
NFKBIE	TF binding region
TMEM151B	CpG island
ENSG00000272442	CpG island
NFKBIE	CpG island
ENSG00000146232	chromatin interactions
ENSG00000096401	chromatin interactions
ENSG00000146221	chromatin interactions

Extended variants
information (count: 81 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:81 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557363956	chr6:44237044-44237045	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs575545243	chr6:44237087-44237088	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs536601568	chr6:44237091-44237092	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs555109810	chr6:44237158-44237159	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs573339104	chr6:44237171-44237172	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs538368464	chr6:44237187-44237188	Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs145623931	chr6:44237221-44237222	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs570160843	chr6:44237222-44237223	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs148466986	chr6:44237239-44237240	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs145221399	chr6:44237260-44237261	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs544570151	chr6:44237267-44237268	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs563343420	chr6:44237290-44237291	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs147596322	chr6:44237368-44237369	Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs548531914	chr6:44237420-44237421	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs551145	chr6:44237448-44237449	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs566047808	chr6:44237495-44237496	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs9381304	chr6:44237507-44237508	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs77986492	chr6:44237549-44237550	Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs190198186	chr6:44237609-44237610	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs374622654	chr6:44237665-44237666	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs571342419	chr6:44237701-44237702	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs538968922	chr6:44237713-44237714	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs201597108	chr6:44237767-44237768	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs371999739	chr6:44237785-44237786	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs182771374	chr6:44237817-44237818	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs375669105	chr6:44237912-44237913	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs547300831	chr6:44237915-44237916	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs187419754	chr6:44237917-44237918	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs367926626	chr6:44237920-44237921	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs554974859	chr6:44237964-44237965	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs573403152	chr6:44238004-44238005	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs559669685	chr6:44238080-44238081	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs371771421	chr6:44238159-44238160	Active TSS Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs111477661	chr6:44238347-44238348	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs534272202	chr6:44238397-44238398	Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs559146952	chr6:44238411-44238412	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs192321730	chr6:44238476-44238477	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs577364888	chr6:44238556-44238557	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs544746443	chr6:44238712-44238713	Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs563050616	chr6:44238765-44238766	Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs112268986	chr6:44238776-44238777	Active TSS Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs79337631	chr6:44238923-44238924	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs375016811	chr6:44238936-44238937	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs560529018	chr6:44239004-44239005	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs528210693	chr6:44239010-44239011	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs370279579	chr6:44239059-44239060	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs5875871	chr6:44239060-44239061	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs199565836	chr6:44239061-44239062	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs546284046	chr6:44239071-44239072	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs149188467	chr6:44239105-44239106	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21720365	CNVD
Osteosarcoma	21197465	CNVD
Gastric cancer	24379144	CNVD
Neuroblastoma	18923191	CNVD
abnormal development	18461090	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21364760	CNVD
Urothelial carcinoma	21177765	CNVD
Colorectal cancer	16790693	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Systemic lupus erythematosus	19287148	CNVD
Colorectal cancer	19359472	CNVD
Multiple myeloma	16616336	CNVD
Chordoma	18071362	CNVD
Follicular lymphoma	16790693	CNVD
Osteosarcoma	19286668	CNVD
Neurocytoma	17123091	CNVD
Myelofibrosis	22110671	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Ovarian cancer	20844748	CNVD
Cancer	20164920	CNVD
lymphocytic leukemia	21291569	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:301 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:44233400-44237000	Weak transcription	HMEC	breast
2	chr6:44233400-44237200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr6:44233400-44237400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
4	chr6:44233400-44237800	Weak transcription	Pancreas	Pancrea
5	chr6:44233400-44237800	Weak transcription	Right Ventricle	heart
6	chr6:44233600-44238000	Weak transcription	Right Atrium	heart
7	chr6:44234600-44237200	Weak transcription	Spleen	Spleen
8	chr6:44234800-44238000	Enhancers	GM12878-XiMat	blood
9	chr6:44235400-44237800	Enhancers	Cortex derived primary cultured neurospheres	brain
10	chr6:44235800-44237600	Enhancers	Brain Germinal Matrix	brain
11	chr6:44236000-44237000	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr6:44236000-44237000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
13	chr6:44236000-44237200	Enhancers	H1 Cell Line	embryonic stem cell
14	chr6:44236000-44237600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
15	chr6:44236000-44237600	Enhancers	Fetal Brain Male	brain
16	chr6:44236000-44237600	Enhancers	Fetal Brain Female	brain
17	chr6:44236200-44237200	Weak transcription	Brain Anterior Caudate	brain
18	chr6:44236200-44237800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
19	chr6:44236200-44238400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
20	chr6:44236400-44237600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
21	chr6:44236400-44238800	Weak transcription	Brain Substantia Nigra	brain
22	chr6:44236600-44237400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
23	chr6:44236600-44237400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
24	chr6:44236800-44237000	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
25	chr6:44236800-44237200	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
26	chr6:44236800-44237200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
27	chr6:44236800-44237600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
28	chr6:44236800-44237600	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
29	chr6:44236800-44237600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
30	chr6:44236800-44238000	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
31	chr6:44236800-44238400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
32	chr6:44236800-44238400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
33	chr6:44237000-44237400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr6:44237000-44237400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
35	chr6:44237000-44238200	Bivalent Enhancer	Primary B cells from cord blood	blood
36	chr6:44237000-44238200	Enhancers	HMEC	breast
37	chr6:44237000-44239200	Bivalent Enhancer	HUVEC	blood vessel
38	chr6:44237200-44237400	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
39	chr6:44237200-44237400	Enhancers	Spleen	Spleen
40	chr6:44237200-44237600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
41	chr6:44237200-44237600	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
42	chr6:44237200-44237600	Bivalent Enhancer	Brain Inferior Temporal Lobe	brain
43	chr6:44237200-44237800	Enhancers	Brain Anterior Caudate	brain
44	chr6:44237200-44238000	Bivalent Enhancer	HepG2	liver
45	chr6:44237200-44238000	Bivalent Enhancer	NHEK	skin
46	chr6:44237200-44238200	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
47	chr6:44237200-44238200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
48	chr6:44237200-44238200	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
49	chr6:44237200-44238400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
50	chr6:44237400-44237600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links